Interestingly, knocking down ALKBH5 affects the accumulation of multiple immune cells and transcriptional expression of tumor cells and similarly improves the sensitivity of melanoma to anti-PD-1 drug therapy [16]. This evidence concerns the gene PDCD1 and melanoma.